Linkwell Corporation Signs Letter of Intent to Acquire 70% of Xinjida Trading PTE Limited.

FORT LAUDERDALE, Fla. -- Linkwell Corporation (OTCBB: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, today announced that it has signed a letter of intent to acquire 70% ownership of Xinjida Trading PTE Limited, a Singapore Corporation ("Xinjida"). Xinjida is an international trading company based in Singapore. According to the letter of intent, Linkwell will issue restricted shares to a Xinjida's shareholder on the basis of shareholder equity ended September 30, 2005. Linkwell plans to complete this acquisition by December 31, 2005. Management believes this acquisition could add up to $15 million in additional annual revenues upon completion.

Xinjida is engaged in the international trading business concentrating primarily in chemical and medical industries. The trading market includes China, the United States, Japan, and various European countries.

Linkwell's Chairman and CEO Xuelian Bian stated, "We are extremely excited with this potential acquisition. Although we have our own international trading division now, our plan is to use both companies to create distribution channels worldwide and enhance both our domestic and international trading business. Upon completion of this acquisition, we will be able to consolidate our international trading businesses with a goal of improving profit margins and increasing distribution channels."

Mr. Bian concluded, "With this advancement of our business plan, the Company is well positioned to grow its business substantially in the coming fiscal year. Our goal is to achieve up to $30 million in annual sales for 2006. We believe completion of this acquisition will also allow Linkwell to achieve its goal to qualify for listing on a major U.S. Exchange."

About Linkwell Corporation

Linkwell Corporation is a leading developer, manufacturer, and marketer of disinfectant healthcare products in China through its 90% owned subsidiary Shanghai Likang Disinfectant High Tech Company ("Likang"). Linkwell Corporation is a U.S. corporation headquartered in Boca Raton, Florida and is publicly traded on the OTC Bulletin Board Exchange under the symbol (OTCBB: LWLL).

Linkwell's disinfectant healthcare products are the leading and only nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectant, liquid and tablet products, as well as disinfectant instruments, devices, materials. These may also include air disinfecting machines, hot press bags, disinfection swabs, and disinfection tampons. Through Likang, Linkwell is the only domestic Chinese company that has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of the People's Republic of China. All inventory and order fulfillment is carried out of a 21,500 square foot facility in Shanghai's Jiading district. The company's products have gradually made their way from medical disinfection to also include civil disinfection, industrial disinfection, and agricultural and livestock disinfection.. For more info about the company, please visit http://www.linkwell.us

Safe Harbor Statement

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets.